119 related articles for article (PubMed ID: 25959119)
1. Formulations in paediatric investigation plans (PIPs): Introduction to PIP quality section and regulatory framework.
Wang S
Int J Pharm; 2015 Aug; 492(1-2):332-4. PubMed ID: 25959119
[No Abstract] [Full Text] [Related]
2. Pediatric formulation issues identified in Paediatric Investigation Plans.
Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
[TBL] [Abstract][Full Text] [Related]
3. More than 5 years of European Paediatric Regulation: statistics and industrial experience.
Winzenburg G
Int J Pharm; 2014 Aug; 469(2):260-2. PubMed ID: 24704106
[TBL] [Abstract][Full Text] [Related]
4. Quality considerations of paediatric investigation plans for monoclonal antibodies: A regulatory perspective from the MHRA.
Hussain N; Siapkara A; Branch S
Int J Pharm; 2015 Aug; 492(1-2):338-40. PubMed ID: 25959114
[TBL] [Abstract][Full Text] [Related]
5. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
6. Milk as a medium for pediatric formulations: Experimental findings and regulatory aspects.
Soulele K; Macheras P
Int J Pharm; 2015 Aug; 492(1-2):344-5. PubMed ID: 25959116
[TBL] [Abstract][Full Text] [Related]
7. Paediatric investigation plans for pain: painfully slow!
Davies EH; Ollivier CM; Saint Raymond A
Eur J Clin Pharmacol; 2010 Nov; 66(11):1091-7. PubMed ID: 20821198
[TBL] [Abstract][Full Text] [Related]
8. Proposals for model-based paediatric medicinal development within the current European Union regulatory framework.
Manolis E; Pons G
Br J Clin Pharmacol; 2009 Oct; 68(4):493-501. PubMed ID: 19843052
[TBL] [Abstract][Full Text] [Related]
9. Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigm.
Rose K; Senn S
Pharm Stat; 2014; 13(4):211-3. PubMed ID: 24903307
[TBL] [Abstract][Full Text] [Related]
10. Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?
Rose K; Walson PD
Paediatr Drugs; 2017 Dec; 19(6):515-522. PubMed ID: 28889403
[TBL] [Abstract][Full Text] [Related]
11. The EU paediatric regulation: still a large discrepancy between therapeutic needs and approved paediatric investigation plans.
Wimmer S; Rascher W; McCarthy S; Neubert A
Paediatr Drugs; 2014 Oct; 16(5):397-406. PubMed ID: 25056717
[TBL] [Abstract][Full Text] [Related]
12. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
Mentzer D
Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178
[TBL] [Abstract][Full Text] [Related]
13. Impact of the European paediatric legislation in paediatric rheumatology: past, present and future.
Ruperto N; Vesely R; Saint-Raymond A; Martini A;
Ann Rheum Dis; 2013 Dec; 72(12):1893-6. PubMed ID: 23962457
[TBL] [Abstract][Full Text] [Related]
14. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
15. [Better medicines for children].
Brasseur D
Rev Med Brux; 2006; 27 Spec No():Sp25-8. PubMed ID: 21818889
[TBL] [Abstract][Full Text] [Related]
16. The pediatric studies initiative: after 15 years have we reached the limits of the law?
Milne CP; Davis J
Clin Ther; 2014 Feb; 36(2):156-62. PubMed ID: 24529287
[TBL] [Abstract][Full Text] [Related]
17. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
Carleer J; Karres J
Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
[TBL] [Abstract][Full Text] [Related]
18. Adaptive paediatric investigation plans, a small step to improve regulatory decision making in drug development for children?
Bauer P; König F
Pharm Stat; 2016 Sep; 15(5):384-6. PubMed ID: 27400890
[TBL] [Abstract][Full Text] [Related]
19. Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans.
Piana C; Kliphuis E; Della Pasqua O
Clin Trials; 2013 Apr; 10(2):269-79. PubMed ID: 23335676
[TBL] [Abstract][Full Text] [Related]
20. The use of ethanol in paediatric formulations in New Zealand.
Svirskis D; Toh M; Ram S
Eur J Pediatr; 2013 Jul; 172(7):919-26. PubMed ID: 23440480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
